COX-2 expression has also been reported in meningioma stroma macrophages, and one study has questioned whether anti-inflammatory drugs that block COX-2 can inhibit the inflammatory cascade, interfering with tumor growth, particularly in meningiomas with high indices of Ki67 (39). Here, MKI67 is linked to neoplasm.